Evidence map›Paper›PMID 32548326›Full record

ArticleHeliyon2020

Synthesis, biological evaluation and model membrane studies on metal complexes containing aromatic N,O-chelate ligands.

Alberto Aragón-Muriel, Yamil Liscano-Martínez, Ernesto Rufino-Felipe, David Morales-Morales, Jose Oñate-Garzón, Dorian Polo-Cerón

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Atherogenic Dyslipidemia and Its Association withInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Alberto Aragón-MurielLaboratorio de Investigación en Catálisis y Procesos (LICAP), Facultad de Ciencias Naturales y Exactas, Departamento de Química, Universidad del Valle, Cali 760001, Colombia.
Yamil Liscano-MartínezGrupo de Genética, Regeneración y Cáncer, Facultad de Ciencias Naturales y Exactas, Instituto de Biología, Universidad de Antioquia, Medellín 050010, Colombia.
Ernesto Rufino-FelipeInstituto de Química, Universidad Nacional Autónoma de México, Cd. Universitaria, Circuito Exterior, Coyoacán, México DF 04510, Mexico.
David Morales-MoralesInstituto de Química, Universidad Nacional Autónoma de México, Cd. Universitaria, Circuito Exterior, Coyoacán, México DF 04510, Mexico.
Jose Oñate-GarzónGrupo de Investigación en Química y Biotecnología (QUIBIO), Facultad de Ciencias Básicas, Universidad Santiago de Cali, Cali 760031, Colombia.
Dorian Polo-CerónLaboratorio de Investigación en Catálisis y Procesos (LICAP), Facultad de Ciencias Naturales y Exactas, Departamento de Química, Universidad del Valle, Cali 760001, Colombia.
Universidad del Valle · COUniversidad Nacional Autónoma de México · MXUniversidad de Antioquia · COUniversidad Santiago de Cali · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel lanthanide (Ln) compounds [Ln(L)

Indexed as

Antibacterial activityBenzimidazoleCancerCytotoxicityFluorescenceInorganic chemistryLanthanide complexesModel membranesMolecular dynamics

Identifiers

PMID32548326
PMCPMC7286978
OpenAlexW3033487260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.